Skip to main contentAI and Advanced
/
IOLCP · NSEMarket ticker unavailable · configure an authorised index feed
IO
NSE · Equity shares · Chemical Manufacturing14.67 · 8.06%
IOL Chemicals & Pharmaceuticals Ltd IOLCP
NSE:INR 196.71
BSE:INR 163.15
Data quality and coveragePrice, company fundamentals and optional research feeds are tracked separately.
Headline priceLast market snapshot
Company fundamentalsStale · last-known data
Research sections8 of 9 availableMissing source values remain unavailable, never zero-filled.
Temporary source issue: live-price. Available sections remain usable while the affected layer retries on a later request.
AI analysis and Advanced tools for IOLCP
Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Snapshot
Price and key statistics
Reported and computed values remain separate; missing values are not converted to zero.
Previous closeINR 182.04
Day rangeINR 173.55 — INR 197.9
52-week rangeINR 67.19 — INR 219.04
Volume86.23 L
Market cap4,788.9
P/ENot available
Fundamental highlightsReported values unless marked as computed
Revenue (INR Cr)2,319.06
Net Income (INR Cr)137.64
EPS4.98
Research path: Interpret IOL Chemicals & Pharmaceuticals Ltd's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Validated OHLC
Interactive price chart
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
IOLCPIOL Chemicals & Pharmaceuticals Ltd1d · INR · NSE
Loading validated candles…
Auditable calculations
Daily technical summary
Calculated from validated daily candles. Descriptive research only.
Calculating technicals…
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
Company reporting
Financial statements
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 2,586.95 | 2,382.07 | 2,244.4 |
| Cash Equivalents | 198.36 | Not available | Not available |
| Other Liabilities Total | 10.96 | 6.69 | 6.75 |
| Long Term Debt | 0 | 0 | 0 |
| Common Stock Total | 58.71 | 58.71 | 58.71 |
| Other Current Assets Total | 44.11 | 2.65 | 4.1 |
| Total Assets | 2,586.95 | 2,382.07 | 2,244.4 |
| Current Portof LT Debt/Capital Leases | 1.02 | 0 | 0 |
| Total Equity | 1,798.55 | 1,687.66 | 1,611.51 |
| Long Term Investments | 62.49 | 25.05 | 65.75 |
| Retained Earnings(Accumulated Deficit) | 1,739.84 | 1,412.83 | 1,335.24 |
| Total Common Shares Outstanding | 29.35 | 29.35 | 29.35 |
| Tangible Book Valueper Share Common Eq | 60.77 | 57.04 | 54.47 |
| Total Liabilities | 788.4 | 694.41 | 632.89 |
| Total Debt | 135.42 | 117.04 | 32.76 |
| Short Term Investments | 10.96 | 131.12 | 135.07 |
| Cashand Short Term Investments | 209.32 | 209.29 | 142.76 |
| Total Receivables Net | 603.13 | 563.49 | 526.33 |
| Notes Payable/Short Term Debt | 132 | 117.04 | 32.76 |
| Deferred Income Tax | 84.86 | 77.81 | 66.14 |
| Accounts Receivable-Trade Net | 603.13 | 515.34 | 474.35 |
| Property/Plant/Equipment Total-Net | 1,262.4 | 1,179.18 | 1,021.39 |
| Total Current Liabilities | 690.18 | 609.91 | 560 |
| Total Inventory | 371.07 | 368.02 | 433.15 |
| Accounts Payable | 482.56 | 427.56 | 469.18 |
| Other Currentliabilities Total | 74.6 | 65.31 | 58.06 |
| Total Long Term Debt | 2.4 | 0 | 0 |
| Intangibles Net | 14.71 | 13.46 | 12.61 |
| Other Long Term Assets Total | 19.72 | 9.52 | 9.76 |
| Total Current Assets | 1,227.63 | 1,151.34 | 1,119.77 |
| Capital Lease Obligations | 2.4 | Not available | Not available |
| Accumulated Depreciation Total | Not available | -370.12 | -300.89 |
| Other Equity Total | Not available | -9.6 | -8.16 |
| Prepaid Expenses | Not available | 7.89 | 13.43 |
| Additional Paid-In Capital | Not available | 225.72 | 225.72 |
| Cash | Not available | 78.17 | 7.69 |
| Property/Plant/Equipment Total-Gross | Not available | 1,528.49 | 1,222.45 |
| Note Receivable-Long Term | Not available | 3.52 | 15.12 |
Fundamentals
Valuation and ratios
Valuation
Price to Sale Ratio2.07
Risk and consensus
Source-qualified signals
Risk metrics
Overall RiskHigh risk
Board Risk55.74
Analyst consensus
ConsensusStrong Buy
Consensus score1.00
Analyst opinions1
Strong Sell count0
Sell count0
Hold count0
Buy count0
Strong Buy count1
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Industry context
Peer comparison
Only peers present in the company profile payload are displayed.
Peer data unavailable in the company profile payload.
Shareholding
Ownership
- Promoter
- 62.28%
- FII
- 4.87%
- MF
- 0.02%
- Other
- 32.83%
Company intelligence
Latest relevant news
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Fire and explosion at IOL Chemicals plant in Barnala - HazardExMarket news · 12 Jun 2026, 9:07 pm
Fire and explosion at IOL Chemicals plant in Barnala HazardEx
IOL Chemicals & Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance - MarketsMojoMarket news · 12 Jun 2026, 1:35 am
IOL Chemicals & Pharmaceuticals Ltd Reports Very Positive Quarterly Financial Performance MarketsMojo
IOL Chemicals Reports Minor Fire at Minoxidil Unit; Operations Suspended for 8–10 Days - scanx.tradeMarket news · 11 Jun 2026, 6:26 am
IOL Chemicals Reports Minor Fire at Minoxidil Unit; Operations Suspended for 8–10 Days scanx.trade
IOL Chemicals reports minor fire incident at Minoxidil manufacturing unit in Punjab - CNBC TV18Market news · 10 Jun 2026, 8:51 pm
IOL Chemicals reports minor fire incident at Minoxidil manufacturing unit in Punjab CNBC TV18
Explosion at IOL Chemicals and Pharmaceuticals Ltd in Barnala; no casualties reported - The TribuneMarket news · 10 Jun 2026, 12:32 pm
Explosion at IOL Chemicals and Pharmaceuticals Ltd in Barnala; no casualties reported The Tribune
IOL Chemicals promoters hold no encumbrance on shares in FY26 - scanx.tradeMarket news · 6 Jun 2026, 1:12 pm
IOL Chemicals promoters hold no encumbrance on shares in FY26 scanx.trade
Corporate actions
Events
- annual General MeetingAGM
- board MeetingsQuarterly Results
- board MeetingsAudited Results
- dividendRs.1.0000 per share(50%)Interim Dividend
- board MeetingsQuarterly Results & Interim Dividend
- board MeetingsQuarterly Results
- annual General MeetingAGM
- board MeetingsQuarterly Results
Rusaka Markets Community
Discussion and sentiment for IOL Chemicals & Pharmaceuticals Ltd
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Checking your Rusaka Markets account…
Company profile
Business information
What the company does
Not available
Company facts
- Industry
- Chemical Manufacturing
- Sector
- Chemical Manufacturing
- NSE Code
- IOLCP
- BSE Code
- 524164
Questions
Stock FAQ
What is the symbol and ISIN of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has the symbol IOLCP and ISIN - INE485C01029.
What is the current price of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd is currently trading at INR 196.71.
What are the year high and year low of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a year high of INR 219.04 and a year low of INR 67.19.
What is the market capitalization of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a market capitalization of INR 4,788.90 crore.
What is the P/E ratio of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a P/E ratio of NA.
What is the dividend yield of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a dividend yield of NA.
How is the financial performance of IOL Chemicals & Pharmaceuticals Ltd based on revenue, net income, and EPS?
IOL Chemicals & Pharmaceuticals Ltd has revenue of INR 2,319.06 crore, net income of INR 137.64 crore, and EPS of NA.
What is the book value of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a book value of NA.
What is the debt-to-equity ratio of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a debt-to-equity ratio of NA.
What are the price-to-book and price-to-sales ratios of IOL Chemicals & Pharmaceuticals Ltd?
IOL Chemicals & Pharmaceuticals Ltd has a price-to-book ratio of NA and a price-to-sales ratio of 2.07.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.